Skip to content

Public FDA record

Z-2273-2025: Carotid WALLSTENT Monorail Endoprosthesis Closed Cell Self-Expanding Stent, stent and stent delivery syst

Recall record Z-2273-2025 for Boston Scientific Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2273-2025
Company in FDA record
Boston Scientific Corporation
FDA classification date
Aug 8, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Certain batches are being removed due to an increase in complaints received in which physicians encountered greater than anticipated resistance while attempting to withdraw the stent delivery system (SDS) from the guidewire or embolic protection device (EPD) after successful stent deployment. The most serious potential adverse health consequence is stroke. Other risks include delay to procedure, vessel injury, vessel spasm, or stent disruption/damage necessitating additional intervention.

Source facts

Action
On July 7, 2025, the firm sent "Urgent Medical Device Removal" customer notifications to all affected accounts either via FedEx Overnight Delivery or in person delivery by sales representatives. The letter provided customers with information about identifying the product and instructions for product segregation and return. 1. Further distribution or use of any remaining devices (Attachment 1) affected by this removal should cease immediately. Do NOT use affected devices and remove those devices from your facility s inventory. Segregate the units in a secure place until they can be returned to Boston Scientific. 2. Immediately post this information in a visible location near the affected devices to ensure it is readily accessible to all handlers and users of the device. 3. Forward this notice to any healthcare professional from your organization and to any facilities where affected devices have been transferred, including hospitals or sites within your network. If you are a distributor, this notice must be forwarded to your customers to ensure notification of this device removal is carried out to the end-user level. 4. Complete and return the enclosed Reply Verification Tracking Form via email: BSCFieldActionCenter@bsci.com or fax: BSC Field Action Center 1-763-415-7708. 5. Return affected devices to Boston Scientific. If you have any questions, call the Quality Systems Manager II at 763-494-1700.
Initiated
2025-07-07
Root cause
Process change control
Distribution
Domestic US Nationwide distribution including Puerto Rico. International distribution worldwide.
Recall number
Z-2273-2025
Recall status
Open, Classified
CDRH record ID
214951
FDA classified
2025-08-08
Recall event number
97243

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗